OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.34
+0.15% today
Updated 2026-04-29
Market cap
$3.50B
P/E ratio
18.53
P/S ratio
0.56x
EPS (TTM)
$0.72
Dividend yield
2.55%
52W range
$6 – $13
Volume
9.4M
Organon & Co (OGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
3.01%
Operating margin
16.20%
ROE
30.60%
ROA
6.22%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $10.50B | $1.80B | 56.30% | 31.16% | 17.15% |
| 2018 | $9.78B | $2.15B | 52.00% | 27.68% | 22.02% |
| 2019 | $7.78B | $3.22B | 70.76% | 49.47% | 41.38% |
| 2020 | $6.53B | $2.16B | 67.56% | 43.59% | 33.07% |
| 2021 | $6.30B | $1.35B | 62.21% | 30.38% | 21.43% |
| 2022 | $6.17B | $917.00M | 62.84% | 27.62% | 14.85% |
| 2023 | $6.26B | $1.02B | 59.84% | 21.19% | 16.33% |
| 2024 | $6.40B | $864.00M | 58.02% | 23.21% | 13.49% |
| 2025 | $6.22B | $187.00M | 54.09% | 20.67% | 3.01% |